🇦🇺 Australia Country × Condition
acute myeloid leukemia Clinical Trials in Australia
Active clinical trials for acute myeloid leukemia with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 1, Phase 2, Phase 1 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇦🇺 Australia
Active Trials in Australia (3)
NCT04065399 Phase 1, Phase 2
Recruiting
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Enrollment
447 pts
Country
🇦🇺 Australia
Syndax Pharmaceuticals
View Trial → NCT04771130 Phase 1, Phase 2
Recruiting
A Study of BGB-11417 in Participants With Myeloid Malignancies
Enrollment
260 pts
Country
🇦🇺 Australia
BeOne Medicines
View Trial → NCT05636514 Phase 1
Recruiting
Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS
Enrollment
12 pts
Country
🇦🇺 Australia
Clinical Hub for Interventional Res...
View Trial → Frequently Asked Questions
How many acute myeloid leukemia clinical trials are active in Australia?
There are currently 3 active clinical trials for acute myeloid leukemia with sites in Australia, of which 3 are actively recruiting patients.
How can I join a acute myeloid leukemia clinical trial in Australia?
To join a acute myeloid leukemia clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are acute myeloid leukemia trials in Australia?
Active acute myeloid leukemia trials in Australia span Phase 1, Phase 2, Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology